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. This is an open access article under1. Introduction
Enzymes have been identiﬁed during the last decade to be very useful
catalyst for the synthesis of many natural and also non-natural com-
pounds as exempliﬁed by various reviews (Bornscheuer et al., 2012;the CC BY license (http://creativecommons.org/licenses/by/4.0/).
H2N
N
O
Fig. 1. Levomilnacipran.
458 H. Lechner et al. / Biotechnology Advances 33 (2015) 457–480Grogan, 2012; Nestl et al., 2014; Resch et al., 2011; Simon et al., 2014;
Wells and Meyer, 2014) and books (Faber, 2011; Fessner and
Anthonsen, 2009; Patel, 2006; Riva and Fessner, 2014).
Thereby, the toolbox of enzymes employed for controlled ring-
formation leading to carbo- and heterocycles has expanded, too. The
cyclic products and derivatives thereof are found in pharmaceuticals
or serve as valuable intermediates for the production of biological active
compounds. More than 75% of the most popular brand name drugs
contain heterocyclic scaffolds due to their fundamental role as building
blocks in organic synthesis and their great activity in biological systems
(Dua et al., 2011; Pozharskii et al., 2011).
Examples for three-membered rings are non-natural amino acids
containing a cyclopropane moiety or chiral epoxides used as inter-
mediates in drug syntheses. Four-membered rings are found for in-
stance in antibiotics like β-lactams. Furthermore, various alkaloids
possess ﬁve-membered as well as six-membered rings in their
structures.
This review reveals the potential of biocatalysts for ring formation,
whereby only examples have been chosen for which well described
enzymes were used which can be expressed heterologously and non-
natural substrates were transformed. In case that for one enzyme sever-
al applications have been reported, a focus was laid on the recent liter-
ature. SAM-dependent enzymes were excluded due to limited
preparative applications due to unsolved cofactor recycling. Further-
more, terpene cyclases are not part of this review since excellent re-
views are available (Christianson, 2006; Hammer et al., 2013; Lesburg
et al., 1998). The reactions are grouped from a chemical point of view
according to the size and type of ring formed and not according to the
type of enzyme.
2. Three-membered rings
2.1. Cyclopropanes
In nature cyclopropanes are found mainly in terpenoids, phero-
mones, fatty acid metabolites and unusual amino acids. Wessjohann
et al. (2003) describe in their review the major mechanisms of
cyclopropane-forming enzymes involving either cationic intermediates
or radicals, transition state metal catalysis, photochemical or redox
reactions as well as nucleophilic substitution.
In a recent study, a cytochrome P450 enzyme was engineered to
catalyse oleﬁn cyclopropanation (Coelho et al., 2013a) using diazoacetateTable 1
Cytochrome P450 enzymes used for oleﬁn cyclopropanation. Reactions were catalysed by P450
activities as hemin and could induce cis/trans selectivity as well as optical enrichment. The com
Entry R1 X R2 Catalyst
1 H Me Et P450BM3-CIS
P411BM3-CIS
Hemin
2 H OMe Et P450H2-5-F10
P411BM3-CIS
Hemin
3 H CF3 Et P450H2-5-F10
P411BM3-CIS
Hemin
4 Me H Et P450H2A10
P411BM3-CIS
Hemin
N/A, not available when enantiomers did not separate to baseline resolution.as non-natural reagent mimicking transition-state metal catalysis to
functionalise C_C bonds (Davies and Manning, 2008). The wildtype
enzyme P450BM-3 displayed compared to the free hemin low activity
and a different diastereoselectivity in this isoelectric carbene transfer
reaction via high-valent iron-carbenoid species. Several selected
P450BM-3 variants showed cis/trans selectivity different from hemin as
well as higher activity (Table 1). While hemin produced mainly the
racemic E-product a variant (P411BM3-CIS) showed signiﬁcant preference
for the Z-product. P411 enzymes are spectroscopically different from
P450s and the reduction potential of the Fe3+ bound by heme is in-
creased due to an exchange of the proximal cysteine-ligand of the iron
to a serine to facilitate reduction to catalytic active Fe2+ (Coelho et al.,
2013b). With these enzymes an enantiomeric excess (e.e.) of up to 75%
was reached for the E-product and up to 87% for the Z-isomer. Compared
to hemin, the redesigned enzymes showed a 2- to 22-fold higher total
turnover number (TTN).
One variant (P450BM3-HStar T268A-C400H-L437W-V78M-L181V),
where the above mentioned axial cysteine was changed to a histidine
to increase the reduction potential even further, was used to catalyse
the cyclopropanation of acrylamides (Wang et al., 2014), which are
challenging substrates for transition metal catalysis due to the electron
deﬁciency of the oleﬁn moiety (Wang et al., 2013). A range of different
acrylamides was enantioselectively transformed to the corresponding
cyclopropanes (Table 2) (Renata et al., 2014). This method was used
as the asymmetric key step for the synthesis of levomilnacipran
(Fig. 1), an antidepressant (Renata et al., 2014).
A different reaction pathway to obtain cyclopropanes proceeds via
an intramolecular nucleophilic substitution. For instance, the enzyme
CmaC in the phytopathogenic bacteria Pseudomonas syringae producesand P411 variants as well as by hemin. The variants showed in almost every case higher
plete table is given in the supplementary information of the original publications.
TTN Conversion [%] Z:E %e.e.Z %e.e.E
228 46 78:22 −81 N/A
157 32 93:7 −87 N/A
37 7 6:94 −2 N/A
364 73 11:89 38 N/A
235 47 81:19 −61 N/A
96 19 7:93 0 N/A
198 40 26:74 72 −65
121 24 76:24 −55 −75
9 2 11:89 1 1
168 34 19:81 −31 N/A
86 17 30:70 −34 N/A
77 15 24:76 0 N/A
Table 2
Cyclopropanation of substituted acrylamides with the variant P450BM3-Hstar, where the
axial ligand of the heme iron was changed from a cysteine to a histidine.
Entry R1 R2 R3 TTN Yield [%] d.r. [%] e.e. [%]
1 Me Me H 4900 98 99:1 98
2 Me OMe H 5000 99 99:1 97
3 H 4900 98 98:2 91
4 H 4900 97 96:4 88
5 H 4700 93 99:1 94
6 Ph H H 3800 75 98:2 89
7 H 2500 50 93:7 71
8a Et Et H n.d. 86 98:2 92
9b Et Et p-Me 3800 76 93:7 66
10 Et Et p-OMe 4100 82 96:4 88
11 Et Et p-Cl 4200 83 91:9 59
12 Et Et p-CF3 3900 77 94:6 58
14 Et Et m-Me 4000 80 97:3 87
n.d. not determined.
a Preparative scale: Reaction was performed with 2.6 μM P450BM3-HStar in 80 mL and
158 mg substrate (0.82 mmol), product was puriﬁed (Wang et al., 2014).
b This reactionwas additionally performed employing the corresponding acrylate instead
of the acrylamide yielding the same product (TTN: 4900, yield 98%, d.r. 89:11, e.e. 57%)
(Renata et al., 2014).
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Fig. 2. Cyclopropane formation catalysed by CmaC. The enzyme transforms γ-chloro-L-va-
line, γ-chloro-L-allo-isoleucine, 4,4-dichloro-L-2-aminobutyric acid or γ-chloro-L-2-
aminobutyric acid to the corresponding amino carboxy cyclopropanes.
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for synthesising the toxin coronatine. This amino carboxy cyclopropane-
forming enzyme catalyses the formation of non-proteinogenic amino
acids from γ-chloro substituted α-aminoacyl moieties bound to a
peptidyl carrier-protein (PCP) (Fig. 2) (Kelly et al., 2007). The formation
of cyclobutanes and cyclopentanes was not observed when employing
δ- or ε-chloro-aminoacyl as substrates. The substrate has to be bound
as the corresponding thioester to the phosphopantetheinyl prosthetic
group of the carrier protein domain to be accepted by CmaC, whereby
CmaC tolerates different carrier proteins (e.g., CmaD or CytC2).
In the proposed mechanism, the S-phosphopantetheinyl pros-
thetic group of the carrier protein and a divalent metal (Zn2+
from CmaC) stabilise the aminoacyl carbanion intermediate by
delocalisation via the thioesters enolate; the latter attacks the Cγ
atom to substitute the chloro atom (Fig. 2). This mechanism is relat-
ed to the mechanism of the 1-aminocyclopropane-1-carboxylate
synthase (ACC-synthase) where S-adenosylmethionine is present
instead of the chloride and pyridoxal-5′-phosphate enables the
delocalisation of electrons. The disadvantage of the latter enzyme
is its narrow substrate speciﬁcity (Feng et al., 2000; Jakubowicz,
2002; Yip et al., 1990).Fig. 3. Simpliﬁedmechanismof the peroxygenase for theepoxidation of alkenes consuming
H2O2.2.2. Oxiranes
Epoxides can be generated enzymatically via epoxidation of alkenes
or from halohydrins. The chapter is divided according to the type of
enzymes involved. For the epoxidation, three classes of enzymes are
considered: (i) heme dependent enzymes requiring H2O2 like the
unspeciﬁc peroxygenase and the chloroperoxidase, (ii) enzymes
using molecular O2 like cytochrome P450 enzymes or the xylene
monooxygenase (non-heme iron) and (iii) enzymes relying on FADlike the styrene monooxgenase or a Baeyer–Villiger monooxygenase
(cyclohexanone monooxygenase). Halohydrins are transformed to the
corresponding epoxides by halohydrin dehalogenases via intramolecu-
lar ring closure.2.2.1. Peroxygenases/peroxidases
Recently, an unspeciﬁc peroxygenase (or aromatic peroxygenase; EC
1.11.2.1), ﬁrstly isolated from Agrocybe aegerita (AaeUPO), later also
from Coprinellus radians andMarasmius rotula, was identiﬁed to oxidise
linear, branched and cyclic alkenes via epoxidation and/or allylic
hydroxylation utilising hydrogen peroxide (Peter et al., 2013). This
fungal heme-thiolate peroxygenase works via a similar mechanism as
the P450 enzymes (Fig. 4) except that it exploits the peroxide shunt
consuming hydrogen peroxide instead of molecular oxygen and
NAD(P)H (Fig. 3).
The AaeUPO regio- and stereoselectively epoxidises a range of
linear and cyclic alkenes. A selection of substrates is shown in
Table 3. Additionally, hydroxylation in allylic position was found
for various substrates. Linear 1-alkenes are suspected to alkylate
the heme and therefore to inactivate the enzyme (Peter et al.,
2013). The enzyme was expressed heterologously in Saccharomyces
Table 3
The unspeciﬁc peroxygenase from Agrocybe aegerita epoxidises linear as well cyclic
alkenes with hydrogen peroxide to the corresponding epoxides. Substrates mainly
converted to the corresponding epoxides are shown.a
Entry Substrate Epoxide Alcohol Conv.alcohol
[%]
Conv.epoxide [%]
(e.e. [%])
1 – n.d. 99
2 n.d. 50
3 – n.d. 45
4 – n.d. 96
5 – n.d. 46
6 – n.d. 5 (66 (S))
7 28 64
8 29 67
a The reaction was limited by a substoichiometric amount of H2O2 (ﬁnal concentration
2 mM, except for entry 1 and 2: 1 mM). n.d. not detected.
Fig. 4.Mechanism of epoxidation by P450 enzymes.
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2014).
Furthermore, AaeUPO epoxidised also styrene and its derivatives
with excellent stereoselectivity (N99% e.e.) in several cases and conver-
sions up to 96% (Kluge et al., 2012) (Table 4, entry 4). Cis-substituted
styrene-derivatives were preferred, but also trans-derivatives can
serve as substrate leading to excellent e.e.s (N98%, entry 3). However,
the substrate concentration (1 mM) needs to be improved to apply
the reaction for preparative purpose.
The well-known chloroperoxidase (CPO, EC 1.11.1.10) from
Caldariomyces fumago has been broadly investigated for the epoxidation
of alkenes. Especially, 1,1-disubstituted alkenes resulted in good
e.e.s, although hydroxylation was a common side reaction (Allain
et al., 1993; Colonna et al., 1993; Dembitsky, 2003; Dexter et al., 1995;
Hu and Hager, 1999; Sanﬁlippo and Nicolosi, 2002; Santhanam and
Dordick, 2002).
The drawback of this enzyme is its lowepoxidation rate in comparison
to its high catalase activity and the low tolerance of organic solvents.Table 4
Range of different styrene derivatives oxidised by AaeUPO.
Entry R1 R2 R3 TTN Conversion [%] e.e. [%]
1 H H H 7900 71 7
2 Me H H 10,700 96 29
3 H Me H 2100 19 N98 (1S,2S)
4 H H Me 10,600 95 N99 (1R,2S)
5 11,100 N99 n.a.
6 10,600 95 32
7 10,700 96 2 (1S,2R)
n.a. not applicable.However, these problems were addressed by directed evolution (Rai
et al., 2001) leading to improved epoxidation activity as well as stability.2.2.2. Cytochrome P450 enzymes
P450 enzymes require the heme-iron-centre for epoxidation to
activate molecular oxygen. In general, the P450 enzymes suffer from a
low chemoselectivitywith causes beside epoxidation also the formation
of various other products, especially by hydroxylation.
Themechanismof epoxidation proceeds via compound I as shown in
Fig. 4 (de Visser and Shaik, 2003; de Visser et al., 2002; Groves and
Watanabe, 1986; Meunier et al., 2004). Investigations on the mecha-
nisms were reviewed by Hrycay and Bandiera (2012).
A vast number of enzymes belonging to the P450 family are known
and characterised. For example P450L2 catalyses the epoxidation of
propylene (Groves et al., 1986) or P450cam from Pseudomonas putida
epoxidises 5-methylenylcamphor (Maryniak et al., 1993). Depending
on the choice of the enzyme the (S)- as well as the (R)-enantiomer is
accessible: For instance, P450cam from P. putida gave the (S)-enantiomer
with up to 66% e.e., while P450BM-3 from Bacillus megaterium and
P450terp from Pseudomonas sp. provide the (R)-enantiomer with up to
82% e.e. when transforming styrene and 4-chlorostyrene (Table 5)
(Fruetel et al., 1994). Furthermore, Li et al. (2001) could invert the
enantioselectivity of P450BM-3 for 3-chlorostyrene from 60% (S) to 95%
(R) just with a single mutation F87G.Table 5
Optical purities of epoxidised styrene and styrene derivatives obtained by P450 enzymes.a
Entry Substrate Enzyme e.e. [%]
1 P450BM-3
P450cam
P450terp
20 (R)
66 (S)
76 (R)
2 P450BM-3
P450cam
P450terp
46 (R)
48 (S)
82 (R)
a Substrate concentration: 1–3 mM.
Table 7
Stereoselective epoxidation by P450BM variants yielding either the (R)- or the (S)-epoxide.
Entry Substrate Catalysta TTN Epoxidation selectivity [%] e.e. [%]
1b 1-Pentene P450BM-3 SH-44 1370 93 73 (S)
2b 1-Hexene P450BM-3 SH-44 1090 88 71 (S)
3b 1-Heptene P450BM-3 SH-44 500 85 65 (S)
4b 1-Octene P450BM-3 SH-44 200 84 55 (S)
5b 1-Pentene P450BM-3 RH-47 570 94 60 (R)
6b 1-Hexene P450BM-3 RH-47 610 93 60 (R)
7b 1-Heptene P450BM-3 RH-47 550 95 76 (R)
8b 1-Octene P450BM-3 RH-47 560 92 83 (R)
9c Styrene P450BM-3 139-3 n.d. 100 0
10c Cyclohexene P450BM-3 139-3 n.d. 85 n.d.
11c Propylene P450BM-3 139-3 n.d. 100 n.d.
n.d. not determined.
a Mutations introduced: both SH-44 andRH-47: R47C, V78A, K94I, P142S, T175I, A184V,
F205C, S226R, H236Q, E252G, R255S, I263A,A290V, L353V, E372E; only SH-44: F87V; only
RH-47: A82F, A328V; 139-3 variant: V78A, H138Y, T175I, V178I, A184V, H236Q, E252G,
R255S, A295T, L353V.
b Kubo et al. (2006). 0.1 μM P450 variant in E. coli lysate in phosphate buffer (pH 8,
100 mM), 4 mM substrate, 0.5 mM NADPH, 3 h at 20 °C.
c Farinas et al. (2004). 2 mM substrate (1% v/v methanol; in the case of propylene
saturated buffer was used), enzyme (1.0 μM) in potassium phosphate buffer (0.1 M, pH
8.0), NADPH (200 mM), stirring at room temperature until completion of reaction.
Table 6
Epoxidation of ortho and para substituted styrene derivatives by the variant P450pyrTM.
This biotransformationwas performedwith resting cells at 2mM substrate concentration.
Entry R1 R2 Conv. [%] e.e. [%]
1 F, Cl, Br, CN H 93–97 97–99 (R)
2 CF3, NO2 H 82–94 97–99 (R)
3 H CF3 8 98 (S)
4 H Cl, Br 40–51 96–97 (S)
5 H F 38 43 (S)
Conv. 96%
e.e. 90% (S)
Conv. 96%
e.e. 90% (S)
Conv. 40%
e.e. 58% (S)
Conv. N99%
e.e. 91% (+)
461H. Lechner et al. / Biotechnology Advances 33 (2015) 457–480The substrate scope of the P450 enzymes is rather broad. It has
already been shown in early work that P450cam can oxidise styrene,
cis-β-methylstyrene, and trans-β-methylstyrene (Fruetel et al., 1992).
More recently, a triple mutant of P450pyr monooxygenase from
Sphingomonas sp. HXN-200 (P450pyrTM, I83H, M305Q, A77S) was
engineered to oxidise ortho and para substituted styrene derivatives
with high stereoselectivity yielding the corresponding (R)-epoxides
(Table 6) (Li et al., 2013).
Furthermore, P450BM-3 can be employed to produce epoxides of
unsaturated fatty acids with a moderate to low chemoselectivity
due to the competing hydroxylation reaction (Ruettinger and Fulco,
1981). There are exceptions, like eicosapentaenoic acid (Fig. 5) which
was oxidised regioselectively at the 17,18-oleﬁnic bond to give
(17S,18R)-epoxyeicosatetraenoic acid with close to absolute regio-
and stereochemical selectivity (epoxidation selectivity: 99%, 97% e.e.)
(Capdevila et al., 1996). Similarly, the F87V variant of P450BM-3 led to
the formation of (14S,15R)-cis-epoxyeicosatrienoic acid out of arachi-
donic acid (Fig. 5) with perfect selectivities (chemo- and regioselec-
tivity: N99%, e.e. 99%) (Graham-Lorence et al., 1997).
The regioselective epoxidation was also exploited for the epoxida-
tion of geranylacetone (Fig. 5) with 90% conversion to 9,10-epoxy-
geranylacetone with perfect regioselectivity and an e.e. of 97%
using another P450BM-3 variant (R47L, Y51F, F87V). This variant also
transformed structurally related substrates like nerylacetone, howeverFig. 5. Substrates for P450BM-3 and variants thereof converted withonly with moderate regio- and chemoselectivity (Watanabe et al.,
2007).
In a minimal mutant library of P450BM-3 the enrichment of
speciﬁc epoxidation products was observed for different variants
for the oxidation (epoxidation) of terpenes like geranylacetone,
nerylacetone, (4R)-limonene and (+)-valencene (Seifert et al.,
2009). For example, (4R)-limonene was oxidised by the wildtype
P450BM-3 producing various products like racemic mixtures of
(4R)-limonene-1,2-epoxide (30%) and (4R)-limonene-8,9-epoxide
(7%) beside of alcohols. One variant (F87A/A328F) was identiﬁed
during the study giving almost exclusively (4R)-limonene-8,9-ep-
oxide (97%).
To achieve stereoselective epoxidation of terminal alkenes (C5–C8),
P450BM-3 was engineered further leading to a number of variants of
interest (Table 7) (Farinas et al., 2004; Kubo et al., 2006). They show
moderate to good stereoselectivity to access the (R)- as well as the
(S)-epoxide depending on the choice of the catalyst.
Another variant was tested aswhole cell catalyst preparation for the
oxidation of α-pinene to yield mainly α-pinene oxide giving trans-
verbenol and myrtenol as side products (Schewe et al., 2008). In many
reports, epoxide formation was only described as side activity (Roiban
et al., 2013; Sowden et al., 2005).perfect regioselectivities. Arrows mark position of epoxidation.
Fig. 6. Precursor of artemisinin prepared by the P450BM-3 G4 variant. The variant was developed for an in-vivo production of artemisinic-(11S),12-epoxide as a precursor for the
antimalarial compound artemisinin.
Fig. 7. Tandem catalysis using oleﬁn metathesis and subsequent enzyme-catalysed epoxidation.
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production of artemisinin, an antimalarial pharmaceutical (Dietrich
et al., 2009). The activity towards the native fatty acid substrates
was reduced and the size of the binding pocket was increased
achieving ﬁnally N99% epoxidation selectivity at 250 mg L−1 by an
in-vivo biotransformation (Fig. 6).
Very recently, a P450BM-3 catalyst was combined in a tandem
cascade with a metal catalyst (a variant of a Hoveyda–Grubbs second
generation ruthenium carbene complex) to perform oleﬁn metathesis
followed by subsequent epoxidation (Denard et al., 2014). The terminal
unsaturated carboxylic acids 10-undecenoic acid and 4-butenyloxy-
benzoic acid were used as substrates together with 3-hexene to form
the epoxide with conversions between 48 and 74%, respectively
(Fig. 7). The important aspect herein is that the enzymatic epoxidation
occurred only with one of the products obtained by the metathesis
reaction.
Wubbolts et al. (1994a,b) used a non-heme diiron enzyme, a xylene
monooxygenase from P. putida, to oxidise styrene as well as 3- and
4-methylstyrene and 3- and 4-chlorostyrene to their corresponding
epoxides with high e.e.s (N90%, except for 4-chlorostyrene: 37%). Later,
it was shown that this enzyme can be used as resting cells leading to a
productivity ofmore than 2 g h−1 L−1 for (S)-styrene (Panke et al., 1999).Fig. 8. Simpliﬁed mechanism of styrene monooxygenase catalysed epoxidation.2.2.3. Flavoproteins
Flavoproteins catalyse a broad range of oxygenation reactions (for a
review see: Huijbers et al., 2014). The styrene monooxygenase (SMO)
(EC 1.14.14.11) from Pseudomonas sp. VLB120 catalyses the epoxidation
of C_C double bonds of styrenes as well as of secondary allylic alcohols
andnon-conjugated alkenes. Styrenes are stereoselectively transformed
to (S)-styrene oxide (Panke et al., 1998). SMO is a NADH-dependent
ﬂavoprotein monooxygenase (StyA) which needs a reductase (StyB)
to regenerate FADH2 (Fig. 8). The reduced cofactor FADH2 reacts withO2 to give ﬂavin peroxide which acts as oxygenating reagent (Kantz
et al., 2005).
The substrate scope of SMO was investigated by Di Gennaro et al.
(1999) using Escherichia coli JM109 whole cells expressing the two-
component styrene monooxygenase system StyAB. In another study, it
was demonstrated that growing E. coli JM101 cells expressing StyAB can
be used to convert a range of substrates with perfect enantioselectivity
on gramme scale (Table 8) (Schmid et al., 2001).
For an efﬁcient screening method, a colorimetric assay was
developed whereby indole was transformed to indigo (Gursky
et al., 2010). However, for increasing the activity of the enzyme
towards α-methyl and α-ethyl styrene rational design was
Table 8
Biotransformation of alkenes to the corresponding epoxides by living E.coli cells
containing StyAB.
Entry Substrate Yield [%] e.e. [%]
1
R1 R2
1aa H H 76 N99 (S)
1ba Me H 47 N99
1ca H Cl 87 N99
2
R
2aa H 87 N99
2bb OH 84c N99 (40c)
2cb OAc 16 N99
2db COOMe 6c N99 (40c (2R, 3S))
3a,b 36a,c–75a N99 (S) (20c)
4a 53 N98
5a 48 98 (1S, 2R)
6b 44 N99 (S)
7b 10 N99
a Schmidet al. (2001). 2-phase system,phase ratio of 0.5 (secondphase=dioctylphthalate),
volume 2 L, substrate concentration of 2% (v/v) in apolar phase, aeration rate 1 L min−1,
stirrer speed 2000 rpm; 30 °C; pH 7.1, feed rate 10 g h−1 glucose (45% w/v) in a 3 L stir
reactor.
b Di Gennaro et al. (1999). OD600 of 2.0 in sodium phosphate buffer (50 mM, pH 6.8),
20 mM glucose, 30 °C on a rotary shaker in the presence of the substrates (0.5 g L−1) for
4 h, analysed via HPLC and NMR. Optical rotations of puriﬁed products were compared
with literature to determine absolute conﬁguration.
c Diol formation observed, the e.e. of the diol is given in brackets.
Table 9
Biotransformation of styrene-derivatives and non-conjugated alkenes with StyAB2.a
Entry Substrate Yield [%] e.e. [%]
1
R1 R2
1a H H 100 N99 (S)
2a Br H 77 N99
3a H Cl 85 N99
2
R
2a H 38 36
2b p-OMe 5 86
2c o-OH 53 80
2d m-Me 18 29
3 6 13
a Lin et al. (2010). StyAB in resting E. coli cells, potassium phosphate buffer (100 mM,
pH 6.5), 20% v/v bis-(2-ethylhexyl)phthalate, 10 mg substrate, 30 °C, 220 rpm, 24 h.
Table 10
Biotransformation of secondary allylic alcohols with StyAB2. The absolute conﬁguration
was determined only for the ﬁrst substrate.
Entry R e.e. [%] d.e. [%] Yield [%] E
1 Ph N99 (R) 98 50 N200
2 m-FC6H4 N99 94 51 140
3 p-FC6H4 N99 96 50 190
4 m-ClC6H4 97 89 42 34
5 p-ClC6H4 N99 98 46 N200
6 2-Thienyl 98 31 58 3
7 3-Thienyl N99 86 40 23
8 Benzyl N99 85 25 16
9 Cyclohexyl 78 66 52 10
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be kept at N99%. Lin et al. (2010, 2011) discovered a second
SMO from Pseudomonas sp. LQ26 designated StyAB2 which con-
verted non-conjugated alkenes additionally to the known styrene
derivatives (Table 9.).
Epoxidation of secondary allylic alcohols having the alkene moiety
in terminal position by StyAB2 led to a kinetic resolution of the substrate
with an enantioselectivity of up to E N 200 (Lin et al., 2011) (Table 10).
Thus, the expected (R)-epoxides were obtained, which corresponds to
the general (S)-stereoselectivity of these enzymes for styrene type sub-
strates since a switch of CIP priority occurs for the investigated allylic al-
cohols (Lin et al., 2011). To access the (S)-enantiomer, variants were
created whereby one variant (Y73V) showed reverse stereopreference
for 1-phenylcyclohexene switching from 71% e.e. (S,S) to 60% e.e. (R,R)
although with rather low conversion (7% and 10%, respectively) (Lin
et al., 2012).
By screening a metagenomic library for indole formation, Van
Hellemond et al. (2007) identiﬁed a SMO which was named SmoA. This
enzyme catalyses the epoxidation of styrene as well as of o-, m- and p-
chlorostyrene with moderate conversion rates but with high to perfect
stereoselectivity.To provide an alternative solution for the regeneration of the ﬂavin
cofactor required by StyA and thereby avoiding the need of the second
enzyme StyB, Hollmann et al. (2003) used the organometallic complex
[Cp*Rh(bpy)(H2O)]2+ to catalyse a transhydrogenation reaction of
formate to FAD without loss of activity or selectivity of the enzyme
StyA. Another solution was found by Tischler et al. (2009) identifying
StyA2B, a fusion protein from Rhodococcus opacus 1CP consisting of
the reductase unit as well as of the monooxygenase part. However,
the catalyst displayed reduction and oxidation activities two order of
magnitude lower than StyAB. Interestingly, by adding another SMO
(StyA1) identiﬁed in R. opacus 1CP the activity was comparable to the
other SMOs again (Tischler et al., 2010).
Cyclohexanone monooxygenase (CHMO) (EC 1.14.13.22) from
Acinetobacter calcoaceticus NCIMB9871, which is well known for
Baeyer–Villiger oxidations, is also able to catalyse the epoxida-
tion of Michael acceptor-type alkenes (Table 11) (Colonna
et al., 2002; Rial et al., 2008). The phosphor-compounds are re-
lated to (S)-2-hydroxypropylphosphonic acid (HPP), the sub-
strate for the HPP epoxidase for the formation of fosfomycin
Table 12
Conversion and enantioselectivity of a halohydrin dehalogenase from Agrobacterium
radiobacter AD1.a
Entry Substrate Conversion [%] e.e. [%]
1 96 b5
2 92 90 (R)
3 75 72 (R)
a Spelberg et al. (1999). 5 mM substrate, TRIS buffer (100 mM, pH 7.5), 30 °C, shaking.
Table 11
Biotransformation with CHMO.
Entry Substrate Enzyme Yield [%] e.e. [%]
1a CHMO 40 N98 (R)
2a CHMO 10 N98
3b Growing E. coli cells
expressing CHMO
54 n.d.
a Colonna et al. (2002). The oleﬁns (12mM)were reacted at 25 °C under stirring in 10mL
of 0.05 M Tris–HCl buffer, pH 8.6, containing NADPH (0.5 mM), glucose-6-phosphate
(50 mM), 100 units of CHMO and 100 units of glucose-6-phosphate dehydrogenase.
b Rial et al. (2008),Whole cells (1mL, at timepoint of induction) and the ketone substrate
(0.3–0.5 mg, as a solution in dioxane or ethanol) were shaken at 24 °C, 120 rpm.
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native substrate.
2.2.4. Halohydrin dehalogenases
Halohydrin dehalogenases (HHDH) catalyse the intramolecular ring
closure of the halohydrin via intramolecular nucleophilic substitution
of the halogen by the β-hydroxy group to yield the corresponding
epoxides (Janssen et al., 2006). The enzymes can also catalyse the
reverse reaction accepting selected nucleophiles leading to the opening
of the epoxide. The mechanism is base-catalysed by an activated
tyrosine (Fig. 9) (de Jong et al., 2003).
Since this review covers ring formations, the application of the
epoxide opening is not detailed here. An overview about various
HHDHs and their substrate scope was recently published (You et al.,
2013). Several halohydrin dehalogenase from different organisms
have been identiﬁed and characterised. In Tables 12 and 13 examples
for the substrate scope and enantiopreference are given. Most HHDHs
display a preference for the (R)-enantiomer, an exception is the HheA-
AD2 which shows (S)-preference (Vlieg et al., 2001). HheC variants
were designed exhibiting a higher catalytic activity and better E values
for the (R)-enantiomer of selected substrates (Table 13, entry 6) (Tang
et al., 2005).
The enzyme HheC was employed in a dynamic kinetic resolution
of racemic halohydrins to give the corresponding epoxides. For
racemisation of the halohydrin an iridacycle was employed (Fig. 10)
(Haak et al., 2008; Jerphagnon et al., 2010). For stabilisation of the
enzyme in the presence of the iridiumcatalyst, a signiﬁcant amount of bo-
vine serum albumin (BSA) had to be added. Furthermore, since
the lifetime of the Ir-catalyst was also limiting, it had to be addedFig. 9. Simpliﬁed reactionmechanismof halohydrin dehalogenases (HHDH) in the revers-
ible dehalogenation/epoxidation reaction.continuously via a syringe pump. The target epoxide was obtained with
up to 90% conversion and up to 98% e.e.
In contrast to HheC, the halohydrin dehalogenase HheB from
Rhodococcus ruber shows only low enantioselectivity (Seisser et al.,
2007), which might be of advantage if the optical purity of the halohy-
drin was already set in a previous step and a single enzyme can be
used to transform the (R)- as well as the (S)-enantiomer. Consequently,
HHDHs were frequently used in cascades or for enantioselective ring
opening of epoxides (selected examples: Schrittwieser et al., 2009;
Molinaro et al., 2010; Majerić-Elenkov et al., 2012; Chen et al., 2013)
and shown for pharmaceutical targets on industrial scale (Fox et al.,
2007).
3. Four-membered rings
3.1. Cyclobutane
Cyclobutane is rarely occurring in nature as a building block. Inmany
cases it is a secondary metabolite employed for defence. Another
example are cyclobutane lipids in ammonium oxidising bacteria
(Damste et al., 2002). Most of natural occurring cyclobutanes are
obtained via photochemical [2 + 2] cycloadditions or carbocation
cyclization/rearrangement processes of terpenes and similar com-
pounds (Hong and Tantillo, 2014).3.2. Oxetanes
Oxetanes are part of several biologically active compounds such as
Taxol®, a drug used in the treatment of cancer, and merrilactone A, aTable 13
Substrates of various halohydrin dehalogenases and their kinetic characterisation.
Entry Km
[μmol]
kcat
[s−1]
kcat/Km
[μmol−1 s−1]
Ea Enzyme
1 Hb 840 0.5 6 ∗ 10−4 n.a. HheCc
2 CH2Cl 10 9.7 0.97 n.a. HheCc
3 (R,S)-CH2OHb 2200 3.7 1.7 ∗ 10−3 n.a. HheCc
4
b
820 1.0 1.2 ∗ 10−3 n.d. HheCc
5 (R)-Ph 370 12.1 0.033 63 HheCc
6 (R)-Ph-NO2d 50 170 3.3 N200 HheC W249Fe
7 (R)-COOEt b50 4 N0.08 N4.8 HheC C153Sf
a E value was calculated by [kcat(R)/Km(R)]/[kcat(S)/Km(S)].
b Brominated substrate is accepted as well.
c Tang et al. (2003).
d Only brominated substrate was tested.
e Tang et al. (2005).
f Schallmey et al. (2013).
Fig. 10. Dynamic kinetic resolution of halohydrins with iridiacycle and HheC.
Table 14
Kinetic constants and turnover rate of the β-lactam synthetase wildtype and variant for
α-methyl and ethyl substituted substrates.
Entry Catalyst R1 R2 Km
(mM)
kcat
(s−1)
kcat/Km
(s−1 mM−1)
1 β-LS H H 0.037 0.87 24
2 β-LS V446A H Me 0.46 0.34 0.7
3 β-LS V446A Me H 0.33 0.014 0.04
4 β-LS H Et 0.06 0.0023 0.04
5 β-LS Et H n.d. ~0.004 n.d.
Conditions: 40mMMES, 40mMHEPES, 35mMTAPS, and 25mMTAPS (pH 8.8, 100mM),
ATP (2 mM), MgCl (12.5 mM).
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of the oxetane ring in nature is still unknown (Kaspera et al., 2010).Table 15
Substrate scope and kinetic data for carbapenam synthetase.
Entry Substrate Producta Km (mM) kcat (s−1) kcat/Km
(s−1 mM−1)
1 n.c. 0.23 0.28 1.23.3. β-Lactams
β-Lactams are produced by fungi to defeat bacteria (Fleming, 1929)
and are commonly employed as antibiotics. The most famous example
is penicillin, but there exist a lot of derivatives like the cephalosporins,
monobactams, and carbapenems (for a review see: Tahlan and Jensen,
2013). The β-lactam synthetase (β-LS, EC 6.3.3.4) is part of the clavulanic
acid production in Streptomyces clavulingerus. Clavulanic acid inhibits β-
lactamases (Bachmann et al., 1998), an enzyme responsible for defeating
bacteria by destroying antibiotics. As a consequence clavulanic acid is
combined with certain antibiotics to overcome resistance.
The mechanism of this enzyme was suggested after mutational and
DFT studies (Fig. 11) (Raber et al., 2009). The substrate is activated by
ATP and the enzyme catalyses via a lysine the intramolecular formal
substitution at the adenylated acyl moiety by the β-nitrogen.
The enzyme was engineered rationally by Labonte et al. (2012) to
accept selectively a (S)-α-methyl substrate to give the (3S)-methyl
β-lactam core (Table 14); the wildtype enzyme transformed the (S)-
as well as the (R)-enantiomer almost equally well (Sleeman et al.,
2002). Additionally, the (S)-α-ethyl substituted derivativewas accepted
by this enzyme (Labonte et al., 2012).
Carbapenems, another class of antibiotics, are synthesised for
example by Pectobacterium carotovorum via the carbapenam synthase
(CarA) (Table 15). The corresponding gene cluster was identiﬁed and
CarA was cloned into E. coli (McGowan et al., 1996). The kinetics of
putative substrates of this enzyme were determined via steady-stateβ
Fig. 11. Reaction and simpliﬁed mechanism of the β-lactam synthetase (β-LS).kinetics (Table 15) (Gerratana et al., 2003). The enzyme forms not
only 4-membered cycles but can also catalyse the formation of 5- and
6-membered rings (Table 15). The enzyme is structurally similar to
the β-LS (22% identity, 36% similarity) and shares the same reaction
mechanism (Gerratana et al., 2003).
Later, this enzyme was used in a two-step biocatalytic cascade to
prepare bicyclic β-lactams. In the ﬁrst step, ω-oxo amino acids and
(alkylated) malonyl-coenzyme were transformed by carboxymethyl-
proline synthase (CarB from P. carotovorum or ThnE from Streptomyces
cattleya, see also the Section 4.2, Tables 17 and 18) to ﬁve-, six- and
seven-membered cyclic intermediates. The latter were cyclized by
CarA to the various bicyclic β-lactams (Fig. 12) (Hamed et al., 2010,
2012).
The isopenicillin-N synthase (IPNS, EC 1.21.3.1) catalyses the forma-
tion of a [3.2.0]-heterobicycle from a tripeptide. The natural peptide2 n.c. 7 0.20 0.027
3 n.c. 4.6 0.122 0.026
4 3.4 0.46 0.13
5 29 0.028 0.0010
6 17 0.19 0.011
7 n.c. 32 0.20 0.0063
n.c. not characterised.
a Identiﬁed via co-elution on HPLC and/or ESI-MS experiments.
Fig. 12. Reaction sequence and products of the synthesis of various N-heterocycles via carboxymethylproline synthase CarB and carbapenam synthetase CarA.
466 H. Lechner et al. / Biotechnology Advances 33 (2015) 457–480consists of L-α-aminoadipic acid, L-cysteine and L-valine leading to the
bicyclic β-lactam antibiotic isopenicillin N (Fig. 13). The mechanism of
this non-heme iron dependent enzyme involves the coordination of
the substrate to the iron via the sulphur atom followed by oxygen up-
take and radical formation of the thioaldehyde which is attacked by
theNH forming the ﬁrst ring (Roach et al., 1997). In the overall reaction,
one molecule of oxygen is consumed giving the bicyclic product and
two molecules of water. The mechanism published in literature
(Brown-Marshall et al., 2010; Lundberg et al., 2009; Roach et al., 1997;
Wirstam and Siegbahn, 2000) was modiﬁed here to close the catalytic
cycle; additionally, the ﬁrst step of the second ring closure was changed
from an ionic mechanism to a radical one. One example where a 7-
membered ring is formed is reported as well (Howard-Jones et al.,
2007).
This enzyme is reported to accept a broad range of different
substrates. The L-α-aminoadipic acid part of the natural substrate
can be substituted by various acids including aromatic ones
(Table 16). Interestingly, also cysteine can be exchanged by a S-
substituted cysteine, although in the mechanism the free SH is required
to coordinate to the iron. Unfortunately, the products of the alternative
substrates were not isolated and characterised, but the transformation
was shown indirectly via two different biochemical assays detecting
lactamase induction in bacteria as well as antibiotic activity (Huffman
et al., 1992).4. Five-membered rings
4.1. Cyclopentanes
In nature, cyclopentane-derivatives are for example products of
the jasmonate biosynthetic pathway (Schaller and Stintzi, 2009) or of
squalene transforming pathways involving cyclases, which are not
covered by this review.
4.2. Five-membered heterocycles with nitrogen
Two enzymes catalysing the formation of 5-membered nitrogen
heterocycles have already been mentioned in the previous chapter,
namely the carboxymethylproline synthase CarB (Fig. 12) and the
isopenicillinN synthase (Fig. 13, Table 16); in both cases, bicyclic products
were obtained.
The carboxymethylproline synthase (CarB) from P. carotovorum
involved in the biosynthetic pathway of carbapenems (Gerratana et al.,
2004; Sleeman and Schoﬁeld, 2004) belongs to the crotonase super-
family and forms (2S,5S)-carboxymethylproline from malonyl-CoA
and glutamate semialdehyde (Fig. 14) (Hamed et al., 2012). The
proposed mechanism was suggested by Batchelar et al. (2008). A
homologue called ThnE was identiﬁed from S. cattleya (Hamed et al.,
2009). Both enzymes are able to decarboxylate CoA thioesters in
Fig. 13. Suggested mechanism of the isopenicillin-N synthase adapted from literature.
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further detail.
The scope of this enzyme is broad, accepting various derivatives
of both substrates and was extended by creating variants showing
different stereoselectivities (Table 17 and Table 18) (Hamed et al.,
2010, 2011).
Very recently, a P411BM3-CIS variant possessing the C440S mutation
replacing the axial cysteine of the heme ligand, which is crucial for
monooxygenation, with a serine, was engineered introducing a T438S
mutation (compare Section 2.1). This P411BM3-CIS T438S variantTable 16
Selected amino acid substitutions in the natural substrate for IPNS.
Part of natural
substrate substituted
Accepted alternative moiety
L-α-Aminoadipic acid
Cys
Val
a
a Howard-Jones et al. (2007) suggest here the formation of a 7-membered cycle.catalysed the intramolecular C–H amination of sulfonylazides leading
to 5-membered heterocycles. The puriﬁed variant showed good
stereoselectivity and higher reactivity compared to hemin for three
substrates (McIntosh et al., 2013) (Table 19).
For instance, for the substrate in Table 19, entry 1, an e.e. of 73% was
reached using pure enzyme, while employing the catalyst as growing or
lyophilised cells led to even higher e.e. (87%) and better TTN (430). The
product was obtained with 58% isolated yield at 80 mM substrate
concentration (McIntosh et al., 2013).
Natural indolocarbazole products like staurosporine, K-252a and
rebeccamycin (Fig. 15) are products of the microorganisms Lentzea
albida (Actinomyces), Nocardiopsis sp. or Lechevalieria aerocolonigenes.
These compounds gained interest because of their inhibitory effects on
mammalian protein kinases and are now used as anti-cancer drugs
(review: Nakano and Omura, 2009). Various enzymes like RebD or
NokB catalysed the formation of pyrrole in these pathways. Selected
non-natural tryptophan derivatives were successfully transformed
with the cytochrome-c dependent RebD from the rebeccamycin
pathway and NokB from the K-252a pathway (Fig. 15) (Chiu et al.,
2009; Nishizawa et al., 2006). Before the cyclisation reaction, the
tryptophan derivatives are oxidised by a ﬂavin dependent enzyme
(RebO or NokA) to the corresponding pyruvic acid intermediate
at the expense of molecular oxygen giving H2O2 as co-product,
which is disproportionated by RebD. RebD transforms also the
indole pyruvic acid derivative, when it is used as the only substrate,
if ammonia ions are added to the reaction (Nishizawa et al., 2006);
interestingly, this could not be shown for the Nok pathway (Chiu
et al., 2009).
Suggestions for the mechanism of RebD were made by
Howard-Jones and Walsh (2005) (Fig. 16). The unstable keto/
imine intermediate is oxidatively coupled via subtraction of two elec-
trons by RebD/NokB, which presumably contains a b-type cytochrome
to reduce O2 as electron acceptor to give the pyrrole product.
Fig. 14. Simpliﬁed mechanism of carboxymethylproline synthase (CarB).
Table 17
Substrate scope of CarB yielding 5- to 7-membered nitrogen heterocycles (pyrrolidine,
piperidine and azepane derivatives).
Entry R1 R2 n d.r. (R:S) Yield (%) Enzyme
1a H H 1 n.a. 44 CarB
2a H H 2 n.a. 11 CarB
3a H H 3 n.a. 6 CarB H229A
4b H CH3 1 55:45 34 CarB
5b H CH3 1 95:5 14 CarB M180V
6b CH3 H 1 9:91 25 ThnE V153A
7b H CH3 2 66:34 7 CarB
8b CH3 H 2 1:99 11 CarB W79A
9b H C2H5 1 65:35 4 CarB
10b C2H5 H 1 32:68 44 CarB W79F
11b C2H5 H 1:99 6 CarB W79A
a Hamed et al. (2010).
b Hamed et al. (2011).
Table 19
Comparison of the reactivity of P411BM3-CIST438S versus hemin for the intramolecular C–H
amination of sulfonylazides.
Entry R1 R2 R3 Catalyst TTN e.e. [%]
1a Et Me H P411BM3-CIST438S 135 73 (S)
1b Et Me H Hemin 3.1 0
2a Me H H P411BM3-CIST438S 22 n.d.
2b Me H H Hemin n.d. n.d.
3a i-pr Me Me P411BM3-CIST438S 27 n.d.
3b i-pr Me Me Hemin 55 n.d.
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for polyketides obtained by polyketide synthases. In their synthetic
pathway, CoA-esters are thereby elongated via decarboxylative
condensation reactions to synthesise complex structures, wherebyTable 18
Substrate scope of CarB yielding carboxymethylproline derivatives with varied substituents on
Entry R d.r.
1 R4 = R5 = CH3 n.a.
2 R5 = CH3 99:1
3 R2 = CH3 n.a.
4 R3 = CH3 n.a.
5 R1 = CH3 n.a.
6 R6 = CH3 n.a.
a Kinetic resolution due to racemic starting material, max. conversion is 50%.many of the enzymes have a cyclisation step included in their reaction
pathway.
The type III polyketide synthase from the chalcone synthase
superfamily (see also Section 5.1) called HsPKSI from Huperizia serrata
catalyses beside other reactions the formation of unnatural polyketide-
alkaloid molecules. Type III polyketide synthase do not use an acyl
carrier protein domain. The synthaseHsPKSI performs a complete seriesthe pyrrolidine ring (Hamed et al., 2012).
Yield (%) Enzyme
48 CarB
39 ThnE H274A
16a CarB
12a CarB
16a CarB H229A
10 ThnE V153A
Fig. 15. Reaction catalysed by RebO/NokA and RebD/NokB in the synthesis of indolocarbazole products.
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with a single active site. Morita et al. (2011) showed the formation
of 5, 6 and 7-membered homo- and heterocycles with this catalyst.
Examples are listed below for the formation of 5-membered nitrogen
heterocycles (Table 20). For preparative applications, the substrate
concentration and the yields need to be improved.
Another type III polyketide synthase which produces non-natural
tetramic acid (2,4-pyrrolidinedione) derivatives was described byFig. 16. Suggested mecWakimoto et al. (2011) (Table 21). The benzalacetone synthase (BAS)
from Rheum palmatum catalyses the decarboxylative condensation of
malonyl-CoA with 4-coumaroyl-CoA (Abe et al., 2001; Table 21).
Furthermore, it can also transform amino acid derivatives like Phe-
SCoA and Trp-SCoA derivatives to form tetramic acid derivatives
(Table 21). According to literature the latter dimerises spontaneously
since a mixture (1:10) of both, the tetramic acid derivative and the
corresponding dimer was detected via HPLC–MS. The enzyme ishanism for RebD.
Table 20
Substrate scope accepted by HsPKS1.a
Entry Substrate 1 Substrate 2 Product Kinetic data/yield
1
2×
Yield 6.4%
Km = 7.6 μM
kcat=4.5× 10−2min−1
2
2×
Yield 2.2%
3
2×
Yield 0.5%
4
2×
Yield 13%
Km = 6.8 μM
kcat=3.2× 10−1min−1
a Substrate 1 (54 μM), substrate 2 (108 μM), enzyme (20 μg) K-Pi buffer (100 mM, pH
6.5, 1 mM EDTA); 30 °C; 4 h.
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entry 13).
The last example for 5-membered nitrogen heterocycles involves a
non-ribosomal peptide synthetase (NRPS). In vivo, this four-subunit
complex produces the siderophore vibriobactin, an iron-chelator of
the catecholamide family, which is synthesised by Vibrio cholera during
limited iron supply.
The complex is set up by four modules (VibE, VibB, VibH, and VibF)
consisting partly of different domains. Predicted by bioinformatic
analysis for heterocyclization,module VibF for example has six domains
(adenylation, peptidyl carrier protein, heterocyclization and condensa-
tion domains) and is therefore responsible for cyclisation. The reaction
pathway and the substrate scope are depicted in Fig. 17 (Marshall
et al., 2001).Table 21
Proposed pathway leading to tetramic acid derivatives catalysed by benzalacetone
synthase (BAS) as well as substrate scope and kinetic data of this enzyme.
Entry Substrate Yielda [%] Km [μM] kcat [min−1]
1 L-Phenylalanoyl-CoA 10.3 11.7 27.8
2 D-Phenylalanoyl-CoA 8.7 3.3 8.1
3 L-Tryptophanoyl-CoA 6.7 9.8 14.7
4 D-Tryptophanoyl-CoA 6.1 8.4 11.0
a The yield refers to the main product.For the transformation of non-natural substrates, the native
substrate threonine mounted on VibF was substituted by a variety
of other amino acids to integrate them into the ﬁnal product.
Serine and cysteine led to product formation of derivatives of
vibriobactin. The cyclization showed a kcat between 74 min−1 for
the native substrate and 10 min−1 for cysteine, while the kcat for
mounting the amino acid on VibF changed from980min−1 (threonine)
to 26 min−1 (cysteine).
4.3. Five-membered heterocycles with oxygen
Sulochrin oxidase from Pencillium frequentans CMI 96659, a putative
Cu2+ dependent enzyme, catalyses the asymmetric synthesis of (+)-
bisdechlorogeodin from sulochrin and additionally accepts two more
non-natural substrates (Table 22) (Huang et al., 1996). The enzyme
forms a new C–O bond to a substituted aromatic carbon, thereby gener-
ating a new chiral quaternary carbon centre.
The biosynthetic benzylisoquinoline pathways of plants yield
a broad range of alkaloids with various pharmaceutical activities
(review by Beaudoin and Facchini, 2014). At various stages in these
pathways the family of cytochrome P450 enzymes CYP719 is responsi-
ble for the formation of methylendioxy bridges. Most of the enzymes
are highly substrate speciﬁc, but some display a minimal substrate
scope tolerating other substituents at the second aromatic ring
(Table 23).
A further example for the formation of oxygen containing 5-
membered rings can be found at the backend of pathways involving
the chalcone synthase. The yellow colour of some ornamental
plants originates from aurones. These are ﬂavonoids which contain
a benzofuran associated with a benzylidene linked in position 2. The
aureusidine synthase is responsible for a cyclisation reaction lead-
ing to the 5-membered ring and the introduction of a hydroxy moiety
on the phenol ring (Table 24). A 5-membered ring size is less common
for ﬂavonoids which possess mainly 6-membered rings. The glycosylat-
ed, binuclear copper enzyme aureusidine synthase is an oxidase puriﬁed
fromplants. A small set of substrates possessing the basic scaffoldwith a
varied substitution pattern was transformed by the enzyme (Nakayama
et al., 2001). Hydrogen peroxide was added but not consumed for sub-
strates bearing no hydroxyl group at R3 — it seems to work like an acti-
vator (Sato et al., 2001).
5. Six-membered rings
Although six membered rings are very common in nature (for
instance, in cofactors and vitamins, DNA bases, amino acids and
many natural products) the enzymes for the synthesis of these com-
pounds seem to be rather speciﬁc since just a few examples satisfy
our criteria transforming non-natural substrates and being heterolo-
gously expressable and not being terpene cyclases. In the following
selected examples carbocycles are formed as well as O- and N-
heterocycles; in case a carbocycle is formed, it is always a benzene
derivative.
5.1. Benzene derivatives and O-heterocycles by polyketide synthases
Enzymes of the chalcone synthase superfamily catalyse the forma-
tion of a variety of carbon backbones of plant secondary metabolites
like chalcones, stilbenes, phloroglucinols, resorcinols, benzophenones,
biphenyls, bibenzyls, chromones, acridones, pyrones, and curcuminoids.
The chalcone synthases belong to the type III polyketide synthases and
originate from plants as well as from bacteria. They catalyse after load-
ing of the starter molecule, the decarboxylative elongation of CoA-ester
subunits followed by different types of cyclisation (Fig. 18).
The enzymes of this family differ (i) by their CoA-ester starter unit,
(ii) the number of elongation steps and (iii) the kind of cyclisation
occurring. Cyclisation may occur via Claisen-type or Aldol-like
Fig. 17.Reaction pathway and scope of the vibriobactin producing non-ribosomal peptide synthase. VibE activates the substratewith ATP andmounts it on the acyl carrier protein domain
of VibB. VibF has an activation domain itself and mounts the activated substrate on its peptidyl carrier protein domain. The cyclisation domains of VibF close the ring and elongate the
molecule via the condensation domains and the product of VibH.
Table 22
Substrate scope of sulochrin oxidase.
Entry R1 R2 Activity [%] Isolated yield [%]a
1 H H 100 33
2 Cl Cl 195 n.d.
3 H Cl 8 n.d.
a Scale: 0.4 mmol.
Table 23
Substrate scope of methylendioxy bridge-forming cytochrome P450 enzymes. CYP719A2
and CYP719A3 are from Eschscholzia californica (Ikezawa et al., 2007), CYP719 from Coptis
japonica (Ikezawa et al., 2003) and CYP719A13 from Argemone mexicana (Chavez et al.,
2011).
Entry R1 R2 R3 Enzymes
1 OH OMe H CYP719A2, CYP719A3, CYP719A13
2 OMe OMe H CYP719, CYP719A3, CYP719A13
3 OMeO H CYP719A2, CYP719A3, CYP719A13
4 H OMe OH CYP719A13
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(2010), Zhou et al. (2010), Abe (2012) and Stewart et al. (2013)
analysed these enzymes in reviews.
Here we present just the main features of these enzymes and give
some examples of the variety of enzymes and products (Table 25).
Enzymes showing Claisen-type cyclisations are for example chalcone
synthase (entry 1), phlorisovalerophenone synthase (entry 2), ben-
zophenone synthase (entry 3), and the acridone synthase (entry
11). Olivetol and stilbene sythases uses an Aldol-type cyclisation
(entries 9, 10).
The chalcone synthase exhibits a very broad substrate scope
(Table 25, entry 1) and produces naringenin chalcone and derivatives
thereof as well as some triketide and tetrakedite by-products out of
p-coumaroyl-CoA and malonyl-CoA. It accepts 4-substituted and
thiophene or furan containing analogues of p-coumaroyl-CoA,
phenylacetyl-CoA, benzoyl-CoA and up to C12 aliphatic chain CoA esters.
Table 24
Reactions and substrate scope of aureusidine synthase.
Entry R1 R2 R3 Rel. activity [%]
1 OH OH H 100
2 GlcO OH H 220
3 OH H H 37
4a OH OH OH 2210
5a GlcO OH OH 2496
6a OH H OH 376
a H2O2was omitted, this led to the formation of two products, themain product had R4=H, theminor product (ratio between 5:1 and 23:1) had this position hydroxylated (R4=OH).
472 H. Lechner et al. / Biotechnology Advances 33 (2015) 457–480The CoA can be substituted in some cases with N-acetylcysteamine.
Variants are even able to convert bulky substrates like N-
methylanthraniloyl-CoA (Jez et al., 2002).
As elongation unit usually malonyl-CoA is used, which can be
substituted in some cases by methylmalonyl-CoA or its N-
acetylcysteamine (NAC) esters (Fig. 19) (Oguro et al., 2004).
The phlorisovalerophenone synthase (Table 25, entry 2) uses
isovaleryl-CoA or isobutyryl-CoA to catalyse the formation of
phlorisovalerophenone or phlorisobutyrophenone, intermediates of
the hop bitter acids and products in Cannabis sativia (Paniego et al.,
1999).Fig. 18.Overviewof the reaction pathway of type III polyketide synthases of the chalcone superf
claisen-type cyclisations.For the benzophenone synthase (Table 25, entry 3) p-coumaroyl-
CoA is replaced by benzoyl-CoA and leads to the same corresponding
products as the chalcone synthase (Liu et al., 2003).
The acridone synthase (Table 25, entry 11) produces 1,3-dihydroxy-
N-methylacridone (Lukacin et al., 2001).
All these synthases share high similarity which could be shown with
an acridone synthase triple mutant (S132T/A133S/V265F) exhibiting the
same catalytic activity as the chalcone synthase (Lukacin et al., 2001).
Recently a type III polyketide synthases was found in a fungi,
performing a reaction very similar to the reactions carried out
by the chalcone synthase superfamily but using as secondamily. Products are synthesised either via lactonisation or they are obtained by aldol-like or
Table 25
Homologues of type III polyketide synthases of the chalcone superfamily and their preferred substrates and products.
Entry Starter molecule Elongation molecule Selected products Enzyme
1 Chalcone synthase
2 Phlorisovalerophenone synthase
3 Benzophenone synthase
4 Chalcone synthase
5 Styrylpyrone synthase
6 2-Pyrone synthase
7 Aspergillus oryzae
CsyB
8 Stilbene synthase, octakedite synthase
9 Stilbene synthase
10 Olivetol synthase
11 Acridone synthase, chalcone synthase F215S
12 Bibenzyl synthase
13 Benzalacetone synthase
ig. 19. Synthesis of triketide pyrones by amodule of erythromycin PKS from Saccharopolyspora erythraea. A. Reaction starting with a diketide and one extension step. B. Reaction starting
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with a monoketide and two extension steps before cyclisation.
Table 26
Kinetic data of different products of olivetol synthase with different substrates.
Entry R Product 1 Product 2 Product 3
kcat/Km [s−1 M−1] kcat/Km [s−1 M−1] kcat/Km [s−1 M−1]
1 n-C5H11 811 280 1013
2 n-C3H7 134 129
3 CH2CH(CH3)2 98.4
4 n-C7H15 107
Table 27
Substrate scope and kinetic data of strictosidine synthases with secologanin as aldehyde.
Entry Amine R kcat/Km [s−1 mM−1] Enzyme
1 H 147.9a/2.03b RsSTR/CrSTR
2 F 0.10b CrSTR
2 F 144.6a/0.10b RsSTR/CrSTR
3 OH 249.29a/0.0012b RsSTR/CrSTR
4 Me 23.35a RsSTRV208A
5 OMe 22.18a RsSTRV208A
6 F 171.84a/0.10b RsSTR/CrSTR
7 Me 14.37a RsSTRV208A
8 OMe 54.27a RsSTRV208A
9 F 0.14b CrSTR
10 Me 0.024b CrSTR
c d b
a Loris et al. (2007). K-Pi buffer (50mM, pH7.0) puriﬁed enzyme (200 or 800 μg), 35 °C.
b McCoy et al. (2006). NaH2PO4 (100 mM, pH 6.8) puriﬁed enzyme (1 μM) 30 °C.
c Wu et al. (2012). STR (0.2 mg/mL), substrates (each 10 mM), K-Pi buffer (50 mM pH
7.0), 2 h, 28 °C, 450 rpm.
d Zou et al. (2010). STR1-His6 (5.0mg, purity around 90%), K-Pi buffer (50mM, pH7.0),
immobilised on a Ni–NTA column. 7-Aza-tryptamine (0.4 g, 2.5 mmol) and 1.1 g
secologanin (88% purity, 2.5 mmol) each compound in K-Pi buffer (50 mM, pH = 7.0,
200 mL). Both solutions were pumped through the column, at a speed of 0.5 mL/min at
low temperature (4–6 °C). (1.3 g) was subjected to preparative HPLC to afford pure 12-
aza-strictosidine (0.7 g, yield: 50.2%).
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et al., 2014).
Another enzyme within this superfamily is the olivetol synthase
(Table 25, entry 10). This enzyme was identiﬁed to be responsible for
the synthesis of alkylresorcinol moieties of cannabinoids in Cannabis
sativa (Table 26) (Taura et al., 2009). In this example a drawback of
these enzymes becomes obvious, namely that in many cases several
(by-)products are formed.
The benzalacetone synthase (Table 21, Table 25, entry 13) is a
versatile enzyme as reviewed by Shimokawa et al. (2012).
In most of the studies the substrate concentration with the enzymes
of this superfamily was rather low and in the μM range. However, it
was shown that substrate concentrations even higher than 100 mM
are possible (Wanibuchi et al., 2007).
A polyketide synthase (PKS) was used for the semi preparative
preparation of triketide pyrones (Fig. 19) (Hughes et al., 2012). For this
purpose parts of the modular erythromycin PKS from Saccharopolyspora
erythraea (Khosla et al., 2007) were expressed in E. coli (construct
EryMod6EryTE). The lysate transformed synthetically prepared diketidesFig. 20. Reaction carried out by strictosidine synthase (STR) and proposed mechanism of this enzyme.
Fig. 21. Reaction and mechanism of norcoclaurine synthase (NCS).
Table 28
Conversion of dopamine derivatives with 4-hydroxyphenylacetaldehyde.
Entry Amine R Conversion [%] (e.e. [%]) kcat [s−1] Enzyme
1 OH 60a/99b,c (N95 (S)) 6.4d CjNCS2/TfNCS
2 H 73b,c (N95 (S)) 6.0d CjNCS2
3 OMe n.d. 6.0d TfNCS
4 33e,c n.d. CjNCS2
n.d. not determined.
a Ruff et al. (2012). TRIS buffer (100mM, pH7), substrates (each1mM), TfNCS (84 μg/mL),
3 h, room temperature
b Yield.
c Pesnot et al. (2012). HEPES (100 mM, pH 7.4) substrates (amine 100 μM, aldehyde 1
mM) enzyme (140 mU, 1 h, 37 °C, e.e. determined by HPLC).
d Luk et al. (2007). KPi buffer (200 mM, pH 7.5), enzyme (2.1 μg/mL), 37 °C, only for
TfNCS.
e Conversion determined via ﬂuorescence assay for residual amine.
Table 29
Conversion of different aldehydes with dopamine.
Entry Aldehyde R
1 OH
2 H
3 F
4 Br
5 Me
6 OMe
7 OCF3
8 OH
9 OMe
10 Me
11 F
12 Me
13 F
14 R1 = R2 = OH
15 R1 = R2 = OMe
16 R1 = OMe, R2 = OH
17
18
19
20 i-propyl
21 benzyl
22 ethyl
23 pentyl
24 R1 = H
R2 = OMe or OH
25 R1 = OH
R2 = H
26 R1 = R2 = H
27
28
29
a Ruff et al. (2012). TRIS buffer (100 mM, pH 7), substrates (each 1 mM), TfNCS (84 μg/mL),
b Yield; e.e. determined by HPLC.
c Pesnot et al. (2012). HEPES (100 mM, pH 7.4) substrates (amine 100 μM, aldehyde 1 mM
amine).
d Nishihachijo et al. (2014). Tris–HCl (100 mM, pH 7, 1% DMSO) substrates (for preparative
with enzyme, 0.5–16 h, 30 °C, e.e. determined via HPLC.
e The ortho-addition product was formed as well with 11% yield (Pesnot et al., 2012).
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yield the triketide products. For the latter step a promiscuous malonyl-
CoA ligasewas used. This enzyme—MatB from Streptomyces coelicolor—
accepts amongst others NAC as polyketide extender unit (Hughes and
Keatinge-Clay, 2011).
The drawback of this reaction is the hydrolytic activity towards
thioesters of this enzyme yielding in only 12% product formation
when carrying out a preparative scale synthesis starting from 200 mg
(21 mM) diketide (Fig. 19 A, R1 = n-propyl, R2 = H).
The enzyme is also able to incorporate two malonyl-units via
decarboxylative condensation when starting with a monoketide before
cyclisation occurs (Fig. 19B).5.2. Six-membered N-heterocycles
5.2.1. Cyclisation via condensation
Examples for the formation of 6-membered N-heterocycles have
already been mentioned above like with the carboxymethylprolineConversion [%] (e.e [%]) Enzyme
60a/99b,c (N95 (S)) TfNCS/CjNCS2
51a/54c TfNCS/CjNCS2
71a/83c TfNCS/CjNCS2
77b,c (N95 (S)) CjNCS2
57a/99c TfNCS/CjNCS2
69a/87c TfNCS/CjNCS2
65a TfNCS
47c CjNCS2
46c CjNCS2
58a TfNCS
66a TfNCS
66a TfNCS
65a TfNCS
10–25c CjNCS2
69a/10–25c TfNCS/CjNCS2
10–25c CjNCS2
68a/32c TfNCS/CjNCS2
61a TfNCS
36c CfNCS2
52a TfNCS
62c/86b,d (95) CjNCS2
N99d (98) CjNCS2
56b,c,e (N95 (S)) CjNCS2
10–25c CjNCS2
10–25c CjNCS2
54c/0a CjNCS2/TfNCS
42a TfNCS
71a TfNCS
10–25c CjNCS2
3 h, room temperature.
) enzyme (140 mU, 1 h, 37 °C, conversion determined via ﬂuorescence assay for residual
reaction 65 mM amine and between 1.25 and 2.90 equivalents aldehyde), cell free extract
Table 30
Substrate scope, yields and regioselectivity of BBE.
Entry R1 R2 R3 R4 R5 R6 R7 Conversion [%] e.e. 1,2 [%] Regioselectivity 1:2
1 OMe OMe H H H H H 50–52a N97% (S) 88:12
2 OCH2O H H H H H 50–51a N97% (S) 88:12
3 OMe H H H H H H 46–50a,b N97% (S) 90:10
4 OMe OMe OMe H H H H 49–50a,c N97% (S) 88:12
5 H H H H H H H 46–50a,c N97% (S) 86:14
6 OMe OH H OMe H H H 50a n.d. N99:1
7 OMe OH H H H H H 53a n.d. 97:3
8 OH OMe H H H H H 48a n.d. 70:30
9 OH OMe H OMe H H H 53a n.d. 98:2
10 OMe OMe H H OH H H 14a n.d. n.d.
11 OMe OMe H H H F H 50a N97% (S) N99:1
12 OMe OMe H H H H Cl b1a n.d. n.d.
13 OMe OMe H H H H CH3 b1a n.d. n.d.
14 OMe OMe H H H H F 48a N97% (S) b1:99
15 OMe OH H H H H F 49a N97% (S) b1:99
16 OH OMe H H H H F 49a N97% (S) b1:99
n.d. not determined.
a Resch et al. (2012). Tris–HCl (10mM, pH 9, 10mMMgCl2), substrate (6.5mM inDMSO), BBE (0.0049mM), catalase (125mg crude preparation), light-shielded, 200 rpm, 40 °C, 24 h.
b Schrittwieser et al. (2011a). Tris–HCl (10mM, pH 9, 10mMMgCl2), substrate (1.5–2mM in toluene), BBE (0.017mM), catalase (125mg crude preparation), light-shielded, 200 rpm,
40 °C, 24 h.
c Schrittwieser et al. (2011b). Tris–HCl (10 mM, pH 9, 10 mMMgCl2), substrate (65 mM in toluene), BBE (0.017 mM), catalase (125 mg crude preparation), light-shielded, 200
rpm, 40 °C, 24 h.
Fig. 22. The stepwisemechanism of amine oxidation catalysed by the berberine bridge en-
zyme (BBE) leading to a C–C bond formation.
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cascade in Fig. 12) leading beside others also to a [4.2.0]-bicyclic
product.
A group of enzymes leading to 6-membered N-heterocycle are
so-called Pictet–Spenglerases (Stöckigt et al., 2011), whereby until
now two types seem to be of synthetic interest, namely the
strictosidine synthase (STR) and the norcoclaurine synthase (NCS).
Both enzymes are part of the biosynthetic pathways of plants leading
to alkaloids (Beaudoin and Facchini, 2014; El-Sayed and Verpoorte,
2007).
The strictosidine synthase (STR) is part of the terpenoid indole
alkaloid pathway and condenses tryptamine and secologanin to form
3α(S)-strictosidine (Fig. 20) (Treimer and Zenk, 1979). The enzyme
was puriﬁed from different plants (Rauvolﬁa serpentina RsSTR,
Catharanthus roseus CrSTR,Ophiorrhiza pumilaOpSTR) and the substrate
scope concerning aldehyde and aminewas elucidated by several groups
(Table 27). Stöckigt et al. (2008) reviewed the substrate scope and
speciﬁcity of this enzyme. Although various substituted indoleamines
and analogues were accepted, the aldehyde part seems to be limited
to secologanin and close derivatives (Chen et al., 2006), although spec-
troscopic data indicated that the STR from O. pumila might transform
other aldehydes at 1 mM substrate concentration (Bernhardt and
O'Connor, 2009; Bernhardt et al., 2010) (only kabs min−1 reported). In
most cases reports were done at very low substrate concentration
(1 mM) reaching up to 10 mM in a selected case (Wu et al., 2012);
nevertheless, preparative transformations have been reported for
instance applying ﬂow chemistry using immobilised enzyme for the
transformation of tryptamine or 7-aza-tryptamine with secologanin
giving strictosidine (1.0 g, 73% yield) and 12-aza-strictosidine (0.7 g,
50% yield), respectively (Zou et al., 2010).
The norcoclaurine synthase (NCS) catalyses a Pictet–Spengler
reaction in the biosynthetic pathway of benzylisoquinolines leading
to bioactive products like berberine and morphine (Liscombe
and Facchini, 2008). The enzyme condenses dopamine and 4-
hydroxyphenylacetaldeyhde as native substrates to get access to(S)-norcoclaurine (Fig. 21) (Samanani and Facchini, 2002). Homo-
logues from Thalictrum ﬂavum and Coptis japonica are characterised
with respect to a biocatalytical application. The substrate scope of
this enzyme was investigated by various groups (Luk et al., 2007;
Pesnot et al., 2012; Ruff et al., 2012) (Tables 28, 29). Especially the
tolerance towards different aldehydes is rather broad, while the
amine part is limited to compounds bearing a hydroxy moiety in
meta-position to the amino ethyl group needed for catalysis; this in
contrast to the chemical Pictet–Spengler reaction which works e.g.,
nicely with a methoxy moiety in this meta-position. The enzyme
was applied for preparative transformation by Nishihachijo et al.
(2014) as well as for a chemo-enzymatic cascade (Maresh et al.,
2014) where the aldehyde was created in-situ by hypochlorite-
mediated decarboxylation of amino acids. Using a cell-free extract
Table 31
C–H amination of benzenesulfonylazides by P411 variants yielding in 5- or 6-rings.
Entry R1 R2 R3 Enzyme TTN Selectivity e.e. for major product [%]
1 n-Pr Et Me P411BM3-CIS T438S/I263F 361 97:3 99
2 n-Pr Et Me P411BM3 T268A/F87A 187 30:70 99
3 n-Bu n-Pr Et P411BM3-CIS T438S/I263F 178 90:10 99
4 n-Bu n-Pr Et P411BM3 T268A/F87A 128 3:97 99
5 EtO2C Et Me P411BM3-CIS T438S/I263F 192 95:5 97
6 EtO2C Et Me P411BM3 T268A/F87A 130 5:95 99
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aldehyde were converted to 6,7-dihydroxy-1-phenethyl-1,2,3,4-
tetrahydroisoquinoline and to 6,7-dihydroxy-1-propyl-1,2,3,4-
tetrahydroisoquinoline (Table 30, entries 20 and 22) (Nishihachijo
et al., 2014).
5.2.2. Oxidative/reductive cyclisation
Another cyclizing enzyme in the benzylisoquinoline pathway is
the berberine bridge enzyme (BBE). The enzyme is a bi-covalently
bound ﬂavin dependent oxidase converting the alkaloid (S)-reticuline
to (S)-scoulerine through an intramolecular C–C formation (Fig. 22).
Molecular oxygen is thereby used to regenerate the cofactor giving
hydrogen peroxide as a side product. The mechanism involves the
abstraction of a hydride from the CH3–N group and concerted ring
closure by the attack of the phenolate (Gaweska et al., 2012; Winkler
et al., 2008). The enzyme was cloned from Eschscholzia californica and
heterologously expressed in Komagataella pastoris (known as Pichia
pastoris).
BBE accepts a range of different substituted (S)-reticulinederivatives
to form the corresponding tetrahydroprotoberberines (Table 30).When
starting from the racemate, exclusively the (S)-enantiomer was trans-
formed in a kinetic resolution. Depending on the substitution patterns
regioisomers were found. By choosing appropriate substitution a single
isomer could be obtained.
To circumvent the disadvantages of a kinetic resolution, thus the
limitation to 50% conversion, the BBE catalysed C–C bond formation
was coupled with a simultaneous stereoinversion of the (R)-substrate
to the (S)-enantiomer; the latter was then transformed by BBE. This
was achieved by the use of a monoamine oxidase/borane redox cascade
leading to 70 to 97% conversion of selected substrates (Schrittwieser
et al., 2014a,b).
Recently P450 variants were described forming a 6-ring with a few
model substrates. The P411BM-3 variants (see also Sections 2.1. and
4.2) can catalyse C–H amination of different benzenesulfonylazides
with complementary regioselectivities (Table 31). Two positions
are crucial for this catalysis: F87 for selectivity of α or β amination
yielding either in a 5-ring (α-amination) or in a 6-ring (β-
amination) and I263F which increases activity for 6-ring formation
(Hyster et al., 2014).
6. Conclusion
The review summarises enzymes for three- to six-membered
ring formation which are not cyclases and for which a certain
non-natural substrate scope has already been found. The examples
show that many enzymes are not well characterised yet with re-
spect to possible non-natural substrates, or that only few substrates
have been tested. In some cases, the responsible enzymes need to
be stabilised and further improved for higher reaction rate and
higher stability.Although the review shows only enzymes which have already been
proven to exhibit substrate promiscuity, there is still much more out in
nature to be exploited. Nevertheless, the examples presented here
clearly indicate the potential of enzymes for ring formation and it
gives an extended guideline for biocatalytic retrosynthesis (Turner
and O'Reilly, 2013) to evaluate synthetic possibilities stimulating
further research.Acknowledgement
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